University of Paris 4 - Paris-Sorbonne / Université paris IV Paris-Sorbonne

Disentangling x-ray dichroism and birefringence via high-purity polarimetry (2021) Schmitt AT, Joly Y, Schulze KS, Marx-Glowna B, Uschmann I, Grabiger B, Bernhardt H, et al. Journal article Efficacy, safety and quality of life (QoL) with Lanreotide Autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumors (NETs): CLARINET FORTE study results (2021) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath , Shah T, Pape UF, Thanh TXM, et al. Conference contribution Advanced small intestine well-differentiated neuroendocrine tumors (WD-SiNET): A survey of practice on 3rd line treatment (2021) Lamarca A, Cives M, De Mestier L, Crona J, Spada F, Oberg K, Pavel ME, Alonso-Gordoa T Conference contribution Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article Constraining the contribution of Gamma-Ray Bursts to the high-energy diffuse neutrino flux with 10 yr of ANTARES data (2021) Albert A, Andre M, Anghinolfi M, Anton G, Ardid M, Aubert JJ, Aublin J, et al. Journal article Making sense of missense variants in TTN-related congenital myopathies (2021) Rees M, Nikoopour R, Fukuzawa A, Kho AL, Fernandez-Garcia MA, Wraige E, Bodi I, et al. Journal article INTEGRAL discovery of a high-energy tail in the microquasar Cygnus X-3 (2021) Cangemi F, Rodriguez J, Grinberg V, Belmont R, Laurent P, Wilms J Journal article Simultaneous in-vivo characterization of blood oxygen saturation and perfusion with bimodal multispectral optoacoustic tomography and ultrafast ultrasound Doppler imaging. (2021) Sarkar M, Liva MP, Renault G, Ntziachristos V, Tavitian B, Gateau J Conference contribution ENETS consensus guidelines for synoptic reporting of radiology studies (2021) Dromain C, Vullierme MP, Hicks RJ, Prasad V, O'Toole D, De Herder WW, Pavel ME, et al. Journal article The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021) Ruszniewski PB, Caplin ME, Kunz PL, Bodei L, Hendifar AE, Mittra E, Wolin EM, et al. Conference contribution